These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 38253430)
1. Rate and predictors of insufficient sweat volume in very young infants after pilocarpine gel iontophoresis: prospective, population-based study. Camargos P; Bedran RM; Alvim CG; Sader OG Arch Dis Child; 2024 Mar; 109(4):304-307. PubMed ID: 38253430 [TBL] [Abstract][Full Text] [Related]
2. Comparison of quantitative sweat chloride methods after positive newborn screen for cystic fibrosis. Laguna TA; Lin N; Wang Q; Holme B; McNamara J; Regelmann WE Pediatr Pulmonol; 2012 Aug; 47(8):736-42. PubMed ID: 22786625 [TBL] [Abstract][Full Text] [Related]
3. Newborn screening for cystic fibrosis in Wisconsin: nine-year experience with routine trypsinogen/DNA testing. Rock MJ; Hoffman G; Laessig RH; Kopish GJ; Litsheim TJ; Farrell PM J Pediatr; 2005 Sep; 147(3 Suppl):S73-7. PubMed ID: 16202788 [TBL] [Abstract][Full Text] [Related]
4. Implementation of a quality improvement program to improve sweat test performance in a pediatric hospital. Aqil B; West A; Dowlin M; Tam E; Nordstrom C; Buffone G; Devaraj S Arch Pathol Lab Med; 2014 Jul; 138(7):920-2. PubMed ID: 24568729 [TBL] [Abstract][Full Text] [Related]
6. Sweat chloride concentrations in infants homozygous or heterozygous for F508 cystic fibrosis. Farrell PM; Koscik RE Pediatrics; 1996 Apr; 97(4):524-8. PubMed ID: 8632940 [TBL] [Abstract][Full Text] [Related]
7. Predictors of insufficient sweat production during confirmatory testing for cystic fibrosis. Kleyn M; Korzeniewski S; Grigorescu V; Young W; Homnick D; Goldstein-Filbrun A; Schuen J; Nasr S Pediatr Pulmonol; 2011 Jan; 46(1):23-30. PubMed ID: 20812243 [TBL] [Abstract][Full Text] [Related]
12. [French guidelines for sweat test practice and interpretation for cystic fibrosis neonatal screening]. Sermet-Gaudelus I; Munck A; Rota M; Roussey M; Feldmann D; Nguyen-Khoa T; Arch Pediatr; 2010 Sep; 17(9):1349-58. PubMed ID: 20719482 [TBL] [Abstract][Full Text] [Related]
13. Initial evaluation of a biochemical cystic fibrosis newborn screening by sequential analysis of immunoreactive trypsinogen and pancreatitis-associated protein (IRT/PAP) as a strategy that does not involve DNA testing in a Northern European population. Sommerburg O; Lindner M; Muckenthaler M; Kohlmueller D; Leible S; Feneberg R; Kulozik AE; Mall MA; Hoffmann GF J Inherit Metab Dis; 2010 Oct; 33(Suppl 2):S263-71. PubMed ID: 20714932 [TBL] [Abstract][Full Text] [Related]
14. Diagnostic dilemmas resulting from the immunoreactive trypsinogen/DNA cystic fibrosis newborn screening algorithm. Parad RB; Comeau AM J Pediatr; 2005 Sep; 147(3 Suppl):S78-82. PubMed ID: 16202789 [TBL] [Abstract][Full Text] [Related]
15. Negative sweat test in hypertrypsinaemic infants with cystic fibrosis carrying rare CFTR mutations. Padoan R; Bassotti A; Seia M; Corbetta C Eur J Pediatr; 2002 Apr; 161(4):212-5. PubMed ID: 12014388 [TBL] [Abstract][Full Text] [Related]
16. Clinical outcomes in infants with cystic fibrosis transmembrane conductance regulator (CFTR) related metabolic syndrome. Ren CL; Desai H; Platt M; Dixon M Pediatr Pulmonol; 2011 Nov; 46(11):1079-84. PubMed ID: 21538969 [TBL] [Abstract][Full Text] [Related]
17. Outcomes of Cystic Fibrosis Screening-Positive Infants With Inconclusive Diagnosis at School Age. Gonska T; Keenan K; Au J; Dupuis A; Chilvers MA; Burgess C; Bjornson C; Fairservice L; Brusky J; Kherani T; Jober A; Kosteniuk L; Price A; Itterman J; Morgan L; Mateos-Corral D; Hughes D; Donnelly C; Smith MJ; Iqbal S; Arpin J; Reisman J; Hammel J; van Wylick R; Derynck M; Henderson N; Solomon M; Ratjen F Pediatrics; 2021 Dec; 148(6):. PubMed ID: 34814176 [TBL] [Abstract][Full Text] [Related]
18. Screening for cystic fibrosis in newborn infants: results of a pilot programme based on a two tier protocol (IRT/DNA/IRT) in the Italian population. Corbetta C; Seia M; Bassotti A; Ambrosioni A; Giunta A; Padoan R J Med Screen; 2002; 9(2):60-3. PubMed ID: 12133923 [TBL] [Abstract][Full Text] [Related]
19. Bilateral sweat tests with two different methods as a part of cystic fibrosis newborn screening (CF NBS) protocol and additional quality control. Sands D; Ołtarzewski M; Nowakowska A; Zybert K Folia Histochem Cytobiol; 2010 Sep; 48(3):358-65. PubMed ID: 21071339 [TBL] [Abstract][Full Text] [Related]
20. [Sweat testing practices in German cystic fibrosis centres]. Naehrlich L Klin Padiatr; 2007; 219(2):70-3. PubMed ID: 17405070 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]